Influx Healthtech Ltd vs Procter Gamble Health Ltd Stock Comparison
Influx Healthtech Ltd vs Procter Gamble Health Ltd Stock Comparison
Last Updated on: May 18, 2026
Key Highlights
The Latest Trading Price of Influx Healthtech Ltd is ₹ 280.5 as of 18 May 15:30
. The p/e ratio of Influx Healthtech Ltd changed from 0 to 0 over 9 quarters. This represents a CAGR of 0.0%
The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00%
The market cap of Influx Healthtech Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0%
The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00%
The revenue of Influx Healthtech Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Procter & Gamble Health Ltd for the Sep '25 is ₹ 329.87 crore as compare to the Jun '25 revenue of ₹ 342.77 crore. This represent the decline of -3.76% The ebitda of Influx Healthtech Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Procter & Gamble Health Ltd for the Sep '25 is ₹ 125.22 crore as compare to the Jun '25 ebitda of ₹ 94.37 crore. This represent the growth of 32.69% The net profit of Influx Healthtech Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0%
The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 88.54 crore over 6 quarters. This represents a CAGR of 53.49%
The dividend payout of Influx Healthtech Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0%
The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00%
.
About Influx Healthtech Ltd
Influx Healthtech Limited was originally incorporated on September 28, 2020 as a Private Limited Company as 'Influx Healthtech Private Limited' with the Registrar of Companies, Central Registration Centre.
Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited' and a Fresh Certificate of Incorporation upon the conversion was issued on May 23, 2022 by the Registrar of Companies, Mumbai.
Influx Healthtech Limited is a a Mumbai-based healthcare product-focused company that has carved a niche in manufacturing Soft Gelatin, Tablets, Capsules, Liquid Orals, Oral Powders, Liquid fill capsules, Effervescent tablets, Nutra Pallets, Protein Bars, Cookies, Jellies/ Gummies, External preparations like Creams, Gels, Ointments, External Oils, Soaps, etc.
About Procter & Gamble Health Ltd
Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations.
Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
FAQs for the comparison of Influx Healthtech Ltd and Procter & Gamble Health Ltd
Which company has a larger market capitalization, Influx Healthtech Ltd or Procter & Gamble Health Ltd?
Market cap of Influx Healthtech Ltd is 649 Cr while Market cap of Procter & Gamble Health Ltd is 8,734 Cr
What are the key factors driving the stock performance of Influx Healthtech Ltd and Procter & Gamble Health Ltd?
The stock performance of Influx Healthtech Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Influx Healthtech Ltd and Procter & Gamble Health Ltd?
As of May 18, 2026, the Influx Healthtech Ltd stock price is INR ₹280.5. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5261.9.
How do dividend payouts of Influx Healthtech Ltd and Procter & Gamble Health Ltd compare?
To compare the dividend payouts of Influx Healthtech Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.